Abstract

Case Study: Absorption of Testosterone Cream via Scrotal Delivery

Author(s): Needham Shawn, Needham Shane

Issue: Nov/Dec 2018 - Volume 22, Number 6

Page(s): 466-468

Download in electronic PDF format for $75
  • Case Study: Absorption of Testosterone Cream via Scrotal Delivery Page 1
  • Case Study: Absorption of Testosterone Cream via Scrotal Delivery Page 2
  • Case Study: Absorption of Testosterone Cream via Scrotal Delivery Page 3

Abstract

Transdermal testosterone has been used for years to treat patients with low testosterone symptoms. Clinically, we have monitored patients to evaluate results of testosterone absorption via blood serum concentrations. The data on multiple time points to determine trough and peak concentrations is lacking in the literature. In this case study, we demonstrate the absorption of testosterone cream via scrotal delivery. The data suggests that after application therapeutic levels are reached with concentrations of (1204.7 ng/dL) within two hours. Additionally, consistent concentrations (1320.6 ng/dL) remain beyond six hours. To our knowledge, this is the first study to collect and measure multiple time points for testosterone via transdermal delivery. The research indicates that testosterone via transdermal delivery is an excellent method to achieve therapeutic concentrations of testosterone. Most importantly, the patient’s symptoms resolved without side effects.

Related Keywords

  • testosterone cream
  • scrotal delivery
  • transdermal administration
  • case study
  • topical testosterone cream
  • low testosterone symptoms
  • decreased libido
  • erectile dysfunction
  • lethary
  • loss of lean body mass
  • weight gain

Related Categories

  • CASE REPORTS
  • DOSAGE FORMS/DRUG CARRIERS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • UROLOGY/URINARY TRACT

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2018
Pg. 466-468
Case Study: Absorption of Testosterone Cream via Scrotal Delivery
Author(s): Needham Shawn, Needham Shane
May/Jun 2012
Pg. 248-252
In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream
Author(s): Lehman Paul A, Raney Sam G
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
May/Jun 2017
Pg. 238
Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases
Author(s): Allen Loyd V Jr
Nov/Dec 2000
Pg. 464
Testosterone 1-mg/0.1-mL Topical Vaginal/Scrotal Spray
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 336-343
Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base
Author(s): Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
May/Jun 2015
Pg. 195-203
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Author(s): Guth Michael AS
Sep/Oct 2023
Pg. 358-360
Major Study Affirming the Relative Safety of Testosterone-replacement Therapy
Author(s): Biundo Bruce
Jul/Aug 2009
Pg. 276-279
Hormone Treatment Options for Males: What to Do for Men with Low Testosterone
Author(s): Biundo Bruce
Jan/Feb 2024
Pg. 28-32
Hormone Treatment Options for Males: What to do for Men with Low Testosterone
Author(s): Biundo Bruce
Jul/Aug 2019
Pg. 325-339
Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Author(s): Glaser Rebecca L, York Anne E
Mar/Apr 1999
Pg. 101
Case Report: Testosterone Supplementation in a Vasectomy Patient
Author(s): Jagodzinski Pat
Jul/Aug 2014
Pg. 332-340
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Author(s): Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
Jul/Aug 2009
Pg. 314-317
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Author(s): Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Mar/Apr 2011
Pg. 102-112
Testosterone Levels in an Aging Population: Screen, Measure, and Restore
Author(s): Kells John, DollbaumCharles M
Jul/Aug 2002
Pg. 255-256
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Author(s): Mason Dave
Mar/Apr 1999
Pg. 137
Testosterone-Menthol Eutectic Ointment (2% Testosterone)
Author(s): Allen Loyd V Jr
Mar/Apr 2014
Pg. 151
Testosterone Enanthate 200-mg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2013
Pg. 73
Testosterone Cypionate 100-mg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 1998
Pg. 68
Testosterone Propionate 100-mg/6 mL Cream
Author(s): Allen Loyd V Jr